Back to EXAS
CITADEL ADVISORS LLC EXAS Position History
Exact Sciences Corporation • Healthcare
Quarters held
56
Latest value
$19.7M
Q4 2025
Peak value
$222.3M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $12.6M |
| Q1 2023 | $5.6M |
| Q1 2023 | $99.7M |
| Q1 2023 | $14.2M |
| Q2 2023 | $1.9M |
| Q2 2023 | $24.6M |
| Q2 2023 | $1.9M |
| Q2 2023 | $7.2M |
| Q2 2023 | $222.3M |
| Q2 2023 | $7M |
| Q3 2023 | $17M |
| Q3 2023 | $5.2M |
| Q3 2023 | $115.6M |
| Q3 2023 | $80K |
| Q3 2023 | $12.2M |
| Q3 2023 | $7.8M |
| Q4 2023 | $19.2M |
| Q4 2023 | $7.8M |
| Q4 2023 | $202.7M |
| Q4 2023 | $1.4M |
| Q1 2024 | $12.4M |
| Q1 2024 | $38.3M |
| Q1 2024 | $7.6M |
| Q1 2024 | $136.4M |
| Q1 2024 | $5.4M |
| Q1 2024 | $3.8M |
| Q2 2024 | $16.5M |
| Q2 2024 | $10M |
| Q2 2024 | $7.7M |
| Q2 2024 | $11.7M |
| Q2 2024 | $26.6M |
| Q2 2024 | $16.8M |
| Q3 2024 | $33.8M |
| Q3 2024 | $19M |
| Q3 2024 | $731K |
| Q3 2024 | $4.2M |
| Q4 2024 | $32.4M |
| Q4 2024 | $13.6M |
| Q4 2024 | $6.3M |
| Q4 2024 | $8.8M |
| Q1 2025 | $21.1M |
| Q1 2025 | $7.1M |
| Q1 2025 | $3M |
| Q1 2025 | $6.9M |
| Q2 2025 | $16.4M |
| Q2 2025 | $14.1M |
| Q2 2025 | $6.7M |
| Q2 2025 | $5.5M |
| Q3 2025 | $205.5M |
| Q3 2025 | $16.6M |
| Q3 2025 | $10.1M |
| Q3 2025 | $10.6M |
| Q4 2025 | $102 |
| Q4 2025 | $28.1M |
| Q4 2025 | $8.4M |
| Q4 2025 | $19.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $19.7M | 193.5K | — | — |
| Q4 2025 | $8.4M | 83.0K | — | — |
| Q4 2025 | $28.1M | 277.1K | — | — |
| Q4 2025 | $102 | 1 | — | — |
| Q3 2025 | $10.6M | 194.4K | — | — |
| Q3 2025 | $10.1M | 184.7K | — | — |
| Q3 2025 | $16.6M | 303.0K | — | — |
| Q3 2025 | $205.5M | 3.76M | — | — |
| Q2 2025 | $5.5M | 103.1K | — | — |
| Q2 2025 | $6.7M | 126.5K | — | — |
| Q2 2025 | $14.1M | 264.8K | — | — |
| Q2 2025 | $16.4M | 309.0K | — | — |
| Q1 2025 | $6.9M | 159.0K | — | — |
| Q1 2025 | $3M | 70.0K | — | — |
| Q1 2025 | $7.1M | 163.8K | — | — |
| Q1 2025 | $21.1M | 487.9K | — | — |
| Q4 2024 | $8.8M | 156.0K | — | — |
| Q4 2024 | $6.3M | 112.7K | — | — |
| Q4 2024 | $13.6M | 242.0K | — | — |
| Q4 2024 | $32.4M | 577.5K | — | — |
| Q3 2024 | $4.2M | 4.33M | — | — |
| Q3 2024 | $731K | 10.7K | — | — |
| Q3 2024 | $19M | 278.7K | — | — |
| Q3 2024 | $33.8M | 496.1K | — | — |
| Q2 2024 | $16.8M | 20.47M | — | — |
| Q2 2024 | $26.6M | 30.54M | — | — |
| Q2 2024 | $11.7M | 277.9K | — | — |
| Q2 2024 | $7.7M | 183.4K | — | — |
| Q2 2024 | $10M | 236.6K | — | — |
| Q2 2024 | $16.5M | 390.9K | — | — |
| Q1 2024 | $3.8M | 4.00M | — | — |
| Q1 2024 | $5.4M | 78.6K | — | — |
| Q1 2024 | $136.4M | 1.98M | — | — |
| Q1 2024 | $7.6M | 109.9K | — | — |
| Q1 2024 | $38.3M | 555.2K | — | — |
| Q1 2024 | $12.4M | 180.0K | — | — |
| Q4 2023 | $1.4M | 1.50M | — | — |
| Q4 2023 | $202.7M | 2.74M | — | — |
| Q4 2023 | $7.8M | 104.9K | — | — |
| Q4 2023 | $19.2M | 259.5K | — | — |
| Q3 2023 | $7.8M | 8.99M | — | — |
| Q3 2023 | $12.2M | 13.50M | — | — |
| Q3 2023 | $80K | 1.2K | — | — |
| Q3 2023 | $115.6M | 1.70M | — | — |
| Q3 2023 | $5.2M | 76.3K | — | — |
| Q3 2023 | $17M | 248.8K | — | — |
| Q2 2023 | $7M | 74.2K | — | — |
| Q2 2023 | $222.3M | 2.37M | — | — |
| Q2 2023 | $7.2M | 77.1K | — | — |
| Q2 2023 | $1.9M | 20.0K | — | — |
| Q2 2023 | $24.6M | 261.5K | — | — |
| Q2 2023 | $1.9M | 20.0K | — | — |
| Q1 2023 | $14.2M | 209.7K | — | — |
| Q1 2023 | $99.7M | 1.47M | — | — |
| Q1 2023 | $5.6M | 82.6K | — | — |
| Q1 2023 | $12.6M | 185.9K | — | — |
Other funds holding EXAS
$1.6B
$935.7M
$898.6M
$751.9M
$455.1M